Weight loss after initiating anti-obesity medications and gout among overweight and obesity individuals: a population-based cohort study.
Yuqing ZhangYilun WangNicola DalbethJunqing XieJing WuChao ZengGuang-Hua LeiYuqing ZhangPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
A higher rate of weight loss after initiating orlistat within 1-year was associated with lower risks of incident gout and lower rates of recurrent gout flares among overweight or obese people.